Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortization of GoodwillAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Change in Accured Expenses (2016 - 2026)

Avanos Medical's Change in Accured Expenses history spans 13 years, with the latest figure at $9.5 million for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 223.38% to $9.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$12.9 million, a 13.16% decrease, with the full-year FY2025 number at -$12.9 million, down 13.16% from a year prior.
  • Change in Accured Expenses hit $9.5 million in Q4 2025 for Avanos Medical, up from -$400000.0 in the prior quarter.
  • Over the last five years, Change in Accured Expenses for AVNS hit a ceiling of $57.9 million in Q4 2021 and a floor of -$28.8 million in Q1 2022.
  • Historically, Change in Accured Expenses has averaged -$1.3 million across 5 years, with a median of -$2.8 million in 2021.
  • Biggest five-year swings in Change in Accured Expenses: tumbled 3300.0% in 2023 and later surged 276.04% in 2024.
  • Tracing AVNS's Change in Accured Expenses over 5 years: stood at $57.9 million in 2021, then tumbled by 80.31% to $11.4 million in 2022, then tumbled by 170.18% to -$8.0 million in 2023, then grew by 3.75% to -$7.7 million in 2024, then skyrocketed by 223.38% to $9.5 million in 2025.
  • Business Quant data shows Change in Accured Expenses for AVNS at $9.5 million in Q4 2025, -$400000.0 in Q3 2025, and -$7.2 million in Q2 2025.